Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
Coding for MENVEO
Here you’ll find vaccine product codes and some common administration codes associated with immunization using MENVEO. Select another vaccine here.
Vaccine administration codes are dependent on the services provided. Please refer to the latest edition of Current Procedural Terminology (CPT) for appropriate administration codes, and the latest edition of International Classification of Diseases (ICD) manual for appropriate diagnosis codes.
Description: MENVEO 1-vial presentation is a solution for intramuscular injection supplied as one vial (pink cap) containing MENVEO.1
Dosage: 0.5 mL1
Age Indication: 10 through 55 years of age
Safety and effectiveness of the 1-vial presentation of MENVEO in children aged younger than 10 years have not been established.
NDCs† (Ten doses [10 vials] in package of 10) |
|
|---|---|
10 vials |
NDC 58160-827-03 |
Outer Carton |
NDC 58160-827-30 |
Tip
To promote accuracy, always consult the most current Prescribing Information or product packaging when documenting NDCs.
MENVEO CPT Code – Immunization Administration Codes5‡
Tip
If reporting multiple vaccine administrations given to a patient through age 18 on the same date along with counseling by a qualified healthcare professional, report one administration code (90460) for each vaccine administered.6
- *ICD-10-CM code Z23, Encounter for Immunization, is reported for all vaccines given within an encounter; additional ICD-10-CM coding may be needed.2
- †Note that some payers require an 11-digit NDC, which involves adding a "0" immediately after the first hyphen in each GSK NDC.7 For example, when reporting NDC 58160-827-30 to TRICARE, it becomes NDC 58160-0827-30.
- ‡Adapted from the American Medical Association, CPT 2021 Professional Edition, Current Procedural Terminology (CPT), 2020.
References:
- Prescribing Information for MENVEO.
- 2021 ICD-10-CM official guidelines for coding and reporting. Centers for Medicare and Medicaid Services. Updated January 1, 2021. Accessed April 24, 2023. https://www.cms.gov/files/document/2021-coding-guidelines-updated-12162020.pdf.
- Immunization information systems (IIS): HL7 standard code set, MVX – manufacturers of vaccines. Centers for Disease Control and Prevention. Accessed April 24, 2023. https://www2a.cdc.gov/vaccines/IIS/IISStandards/vaccines.asp?rpt=mvx.
- Immunization information systems (IIS): Current HL7 standard code set, CVX – vaccines administered. Centers for Disease Control and Prevention. Accessed April 24, 2023. https://www2a.cdc.gov/vaccines/IIS/IISStandards/downloads/cvx_list.pdf.
- CPT category I new vaccine codes (including incorporation of ACIP abbreviations listing) long descriptors. American Medical Association. Updated June 30, 2023. Accessed April 24, 2023. https://www.ama-assn.org/system/files/vaccine-long-descriptors.pdf.
- Bright futures coding for pediatric preventive care 2022. American Academy of Pediatrics. Accessed July 3, 2023. https://downloads.aap.org/AAP/PDF/Coding%20Preventive%20Care.pdf
- Office injectable guidelines: national drug code (NDC) pricing and filing tips. Humana Military. Accessed April 24, 2023. https://www.humanamilitary.com/provider/education-and-resources/claims/office-injectable.
Please note that this website is provided for informational purposes only and is not intended to serve as comprehensive training on medical billing and coding. Additional training on medical coding may be required. The information on this website is believed to be accurate as of the date of publication. Users should independently verify accuracy.
Healthcare providers are responsible for making the ultimate decision on when to use a specific product based on clinical recommendations and how to bill for products and related services rendered. Consult third-party insurers' guidelines for specific information regarding the billing and reporting of services rendered.
Description: MENVEO 2-vial presentation is a solution for intramuscular injection supplied in two vials, the contents of which must be combined prior to administration:
- MenCYW-135 Liquid Conjugate Component (gray cap)
- MenA Lyophilized Conjugate Component (orange cap)
Please note that neither component should be given alone.1
Dosage After Reconstitution: 0.5 mL1
Age Indication: 2 months through 55 years of age
NDCs† (Five doses [10 vials] in package of 10) |
|
|---|---|
Five vials containing MenA lyophilized conjugate component |
NDC 58160-958-01 |
Five vials containing MenCYW-135 liquid conjugate component |
NDC 58160-959-01 |
Outer Carton |
NDC 58160-955-09 |
Tip
To promote accuracy, always consult the most current Prescribing Information or product packaging when documenting NDCs.
MENVEO CPT Code – Immunization Administration Codes5‡
Tip
If reporting multiple vaccine administrations given to a patient through age 18 on the same date along with counseling by a qualified healthcare professional, report one administration code (90460) for each vaccine administered.6
- *ICD-10-CM code Z23, Encounter for Immunization, is reported for all vaccines given within an encounter; additional ICD-10-CM coding may be needed.2
- †Note that some payers require an 11-digit NDC, which involves adding a "0" immediately after the first hyphen in each GSK NDC.7 For example, when reporting NDC 58160-827-30 to TRICARE, it becomes NDC 58160-0827-30.
- ‡Adapted from the American Medical Association, CPT 2021 Professional Edition, Current Procedural Terminology (CPT), 2020.
References:
- Prescribing Information for MENVEO.
- 2021 ICD-10-CM official guidelines for coding and reporting. Centers for Medicare and Medicaid Services. Updated January 1, 2021. Accessed April 24, 2023. https://www.cms.gov/files/document/2021-coding-guidelines-updated-12162020.pdf.
- Immunization information systems (IIS): HL7 standard code set, MVX – manufacturers of vaccines. Centers for Disease Control and Prevention. Accessed April 24, 2023. https://www2a.cdc.gov/vaccines/IIS/IISStandards/vaccines.asp?rpt=mvx.
- Immunization information systems (IIS): Current HL7 standard code set, CVX – vaccines administered. Centers for Disease Control and Prevention. Accessed April 24, 2023. https://www2a.cdc.gov/vaccines/IIS/IISStandards/downloads/cvx_list.pdf.
- CPT category I new vaccine codes (including incorporation of ACIP abbreviations listing) long descriptors. American Medical Association. Updated June 30, 2023. Accessed April 24, 2023. https://www.ama-assn.org/system/files/vaccine-long-descriptors.pdf.
- Bright futures coding for pediatric preventive care 2022. American Academy of Pediatrics. Accessed July 3, 2023. https://downloads.aap.org/AAP/PDF/Coding%20Preventive%20Care.pdf
- Office injectable guidelines: national drug code (NDC) pricing and filing tips. Humana Military. Accessed April 24, 2023. https://www.humanamilitary.com/provider/education-and-resources/claims/office-injectable.
Please note that this website is provided for informational purposes only and is not intended to serve as comprehensive training on medical billing and coding. Additional training on medical coding may be required. The information on this website is believed to be accurate as of the date of publication. Users should independently verify accuracy.
Healthcare providers are responsible for making the ultimate decision on when to use a specific product based on clinical recommendations and how to bill for products and related services rendered. Consult third-party insurers' guidelines for specific information regarding the billing and reporting of services rendered.
